25 LC 46 1189
Senate Resolution 347
By: Senators James of the 28th, Jones II of the 22nd, Harrell of the 40th, Wicks of the 34th,
Davenport of the 17th and others
A RESOLUTION
Recognizing the work of German dermatologist Josef Jadassohn who invented the innovative
1
patch-testing medical technique in 1895 and encouraging medical practitioners to consider2
applying patch-testing for patients with a clinical history of metal hypersensitivity prior to3
certain implantation operations; and for other purposes.4
WHEREAS, most implants used in orthopedic operations are composed of metal alloys that5
contain common contact allergens, such as nickel, cobalt, and chromium; and6
WHEREAS, more than 1 million lower extremity total joint replacements are completed7
yearly in the United States and are expected to increase in the coming years; and8
WHEREAS, allergic complications to metal implants often cause problems such as chronic9
joint pain, dermatitis, and joint failure; and10
WHEREAS, nickel is commonly used in alloys due to its strength and durability; and11
WHEREAS, many cases of metal hypersensitivity are due to contact with alloys containing12
nickel; and13
S. R. 347
- 1 - 25 LC 46 1189
WHEREAS, surgeons and dermatologists commonly rely on patch-testing to evaluate
14
patients for potential metal allergy; and15
WHEREAS, the value of patch-testing for patients with a clinical history of metal16
hypersensitivity before implants are placed into bones or joints has been acknowledged by17
research published in JAMA Dermatology, a journal of the American Medical Association.18
NOW, THEREFORE, BE IT RESOLVED BY THE SENATE that the members of this body19
recognize the memory and contributions of medical pioneer Josef Jadassohn and encourage 20
medical practitioners to consider applying patch-testing when evaluating patients with a21
clinical history of metal hypersensitivity prior to certain implantation operations.22
BE IT FURTHER RESOLVED that surgeons and dermatologists are encouraged to work23
together to establish guidelines to identify patients who would benefit from replacements of24
previously implanted contact allergens.25
BE IT FURTHER RESOLVED that the Secretary of the Senate is authorized and directed26
to make copies of this resolution available for distribution to the public and the press.27
S. R. 347
- 2 -